UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

Annals of oncology, 2020-06, Vol.31 (6), p.724-744

2020

Volltextzugriff (PDF)

Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study

Annals of oncology, 2012-12, Vol.23 (12), p.3137-3143

2012

Volltextzugriff (PDF)

Synthesis of 5-arylacetylenyl-1,2,4-oxadiazoles and their transformations under superelectrophilic activation conditions

Beilstein journal of organic chemistry, 2021-09, Vol.17 (1), p.2417-2424

2021

Volltextzugriff (PDF)

Melanoma antigens are biomarkers for ipilimumab response

Journal of the European Academy of Dermatology and Venereology, 2017-02, Vol.31 (2), p.252-259

2017

Volltextzugriff (PDF)

Protective Coatings Based on Titanium Diboride and Carbon Fillers

Protection of metals and physical chemistry of surfaces, 2023-08, Vol.59 (4), p.638-647

2023

Volltextzugriff (PDF)

A Study of Metal-Powder Alloy KhN56KVMTYuB for GTE Disks Under Aggressive Impact of Sodium Chlorides and Sulfates

Metal science and heat treatment, 2021-11, Vol.63 (7-8), p.363-368

2021

Volltextzugriff (PDF)

Stability of Foam-Silicate Aggregates Against Alkali in Cement

Glass and ceramics, 2018-01, Vol.74 (9-10), p.372-377

2018

Volltextzugriff (PDF)

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response

Clinical pharmacology: advances and applications, 2022-01, Vol.14, p.69-90

2022

Volltextzugriff (PDF)

Crystallization of the Amorphous Phase in Foam Glass as a Method of Decreasing the Alkali-Silicon Reaction

Glass and ceramics, 2016-07, Vol.73 (3-4), p.77-81

2016

Volltextzugriff (PDF)

Intratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a multicenter, phase I/II study

Annals of oncology, 2018-10, Vol.29, p.viii442-viii442

2018

Volltextzugriff (PDF)

3330 Clinical benefits associated with durable response (DR) in patients (pts) with unresected stage IIIB/C/IV melanoma treated with talimogene laherparepvec (T-VEC) or GM-CSF in the randomized phase 3 OPTiM trial (NCT00769704)

European journal of cancer (1990), 2015-09, Vol.51, p.S674-S674

2015

Volltextzugriff (PDF)

3340 Treatment beyond progression in advanced BRAF-mutated melanoma with vemurafenib and cobimetinib: Results from the BRIM7 trial

European journal of cancer (1990), 2015-09, Vol.51, p.S679-S679

2015

Volltextzugriff (PDF)

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S326-S327

2014

Volltextzugriff (PDF)

Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006

EUROPEAN JOURNAL OF CANCER, 2017, Vol.72, p.S122-S123

2017

Volltextzugriff (PDF)

Development and Industrial Tests of the TiB2-Based Composite Material for Local Fractures Repairing of Electrolyzer Bottom Blocks

Russian journal of non-ferrous metals, 2019-07, Vol.60 (4), p.348-353

2019

Volltextzugriff (PDF)

3334 Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM

European journal of cancer (1990), 2015-09, Vol.51, p.S676-S676

2015

Volltextzugriff (PDF)

354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S72-S72

2015

Volltextzugriff (PDF)

24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma

European journal of cancer (1990), 2015-09, Vol.51, p.S722-S722

2015

Volltextzugriff (PDF)

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S271-S271

2013

Volltextzugriff (PDF)

Mössbauer Study of Amorphous Films Deposited from Solutions of Halide-Chalcogenide Glasses in n-Butylamine

Glass physics and chemistry, 2022-10, Vol.48 (5), p.400-402

2022

Volltextzugriff (PDF)

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

The New England journal of medicine, 2015-08, Vol.373 (8), p.726-736

2015

Volltextzugriff (PDF)

270 The Impact of a Tissue Acquisition Program On Research in Molecular Targeted Therapy of Melanoma

European journal of cancer (1990), 2012-11, Vol.48, p.83-83

2012

Volltextzugriff (PDF)

Distribution of chloride ions along the flight path of aircraft (Overview)

Journal of physics. Conference series, 2022-12, Vol.2373 (2), p.22008

2022

Volltextzugriff (PDF)

IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells

The Journal of immunology (1950), 1996-11, Vol.157 (10), p.4282-4285

1996

Volltextzugriff (PDF)

1 – 25 von 1.005

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(847)
Mit Volltextzugriff
(761)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study

Synthesis of 5-arylacetylenyl-1,2,4-oxadiazoles and their transformations under superelectrophilic activation conditions

Melanoma antigens are biomarkers for ipilimumab response

Protective Coatings Based on Titanium Diboride and Carbon Fillers

A Study of Metal-Powder Alloy KhN56KVMTYuB for GTE Disks Under Aggressive Impact of Sodium Chlorides and Sulfates

Stability of Foam-Silicate Aggregates Against Alkali in Cement

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response

Crystallization of the Amorphous Phase in Foam Glass as a Method of Decreasing the Alkali-Silicon Reaction

Intratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a multicenter, phase I/II study

3330 Clinical benefits associated with durable response (DR) in patients (pts) with unresected stage IIIB/C/IV melanoma treated with talimogene laherparepvec (T-VEC) or GM-CSF in the randomized phase 3 OPTiM trial (NCT00769704)

3340 Treatment beyond progression in advanced BRAF-mutated melanoma with vemurafenib and cobimetinib: Results from the BRIM7 trial

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006

Development and Industrial Tests of the TiB2-Based Composite Material for Local Fractures Repairing of Electrolyzer Bottom Blocks

3334 Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM

354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer

24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

Mössbauer Study of Amorphous Films Deposited from Solutions of Halide-Chalcogenide Glasses in n-Butylamine

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

270 The Impact of a Tissue Acquisition Program On Research in Molecular Targeted Therapy of Melanoma

Distribution of chloride ions along the flight path of aircraft (Overview)

IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells

Suchergebnisse filtern